UMass Boston

Recent Publications

82.    Ruetten H, Wegner KA, Zhang HL, Wang P, Sandhu JK, Sandhu SK, Mueller B, Wang  Z, Macoska J, Peterson RE, Bjorling DE, Ricke WA, Marker PC, Vezina CM. Impact of Sex, Androgens, and Prostate Size on C57BL/6J Mouse Urinary Physiology: Functional Assessment. Am J Physiol Renal Physiol. 2019 Aug 7. doi: 10.1152/ajprenal.00270.2019. [Epub ahead of print] PubMed PMID: 31390231.

83.    Gao S, Chen S, Han D, Barrett D, Han W, Ahmed M, Patalano S, Macoska JA, He HH, Cai C. Forkhead domain mutations in FOXA1 drive prostate cancer progression.  Cell Res. 2019 Sep;29(9):770-772. doi: 10.1038/s41422-019-0203-2. Epub 2019 Jul 19. PubMed PMID: 31324883.

84.    Macoska JA, Uchtmann K, Leverson G, McVary KT, Ricke WA. Prostate Transition Zone Fibrosis in Men who Failed Doxazosin, Finasteride, or Combination Therapy in the Medical Therapy of Prostatic Symptoms (MTOPS) Study. J. Urol. 2019; 202: 1-8.

85.    Ruetten H, Wegner KA, Zhang HL, Wang P, Sandhu J, Sandhu S, Morkrid J, Mueller B, Wang Z, Macoska J, Peterson RE, Bjorling DE, Ricke WA, Marker PC, Vezina CM. Insight and Resources From a Study of the "Impact of Sex, Androgens, and Prostate Size on C57BL/6J Mouse Urinary Physiology. Toxicol Pathol. 2019 Dec;47(8):1038-1042. doi: 10.1177/0192623319877867. Epub 2019 Oct 29. PubMed PMID: 31662055; PubMed Central PMCID: PMC6910975. 

86.    Farahmand S, O'Connor C, Macoska JA, Zarringhalam K. Causal Inference Engine:  A platform for directional gene set enrichment analysis and inference of active transcriptional regulators. Nucleic Acids Res. 2019 Dec 16;47(22):11563-11573. doi: 10.1093/nar/gkz1046. PubMed PMID: 31701125.

87.    Ruetten H, Wegner KA, Kennedy CL, Turco AE, Zhang HL, Wang P, Sandhu JK, Sandhu SK, Morkrid J, Wang Z, Macoska J, Peterson RE, Bjorling DE, Ricke WA, Marker PC, Vezina CM. Impact of Sex, Androgens, and Prostate Size on C57BL/6J Mouse Urinary Physiology: Urethral Histology. Am J Physiol Renal Physiol. 2020 Jan 6. doi: 10.1152/ajprenal.00540.2019. [Epub ahead of print] PubMed PMID: 31904290.

88.    Gao S, Chen S, Han D, Wang Z, Li M, Han W, Besschetnova A, Liu M, Zhou F, Barrett D, Luong MP, Owiredu J, Liang L, Ahmed M, Petricca J, Patalano S, Macoska JA, Corey E, Chen S, Balk SP, He HH, and Cai C. Lineage-Specific chromatin binding of FOXA1 is regulated by LSD1-mediated demethylation. Nature Genetics.  [published online ahead of print, 2020 Aug 31]. Nat Genet. 2020;10.1038/s41588-020-0681-7. doi:10.1038/s41588-020-0681-7.

89.    Han D, Owiredu JN, Healey BM, Li M, Labaf M, Steinfeld J, Patalano S, Gao S, Liu M, Macoska JA, Zarringhalam K, Siegfried KR, Yuan X, Rebbeck TR5, Cai C.   Susceptibility-associated genetic variation in NEDD9 contributes to prostate cancer initiation and progression. Cancer Res. 2021 Feb 25:canres.3042.2020. doi: 10.1158/0008-5472.CAN-20-3042. Epub ahead of print. PMID: 33632899.

90.    Tantiwetrueangdet A, Panvichian R, Sornmayura P, Leelaudomlipi S, Macoska, JA. PCNA-associated factor (KIAA0101/PCLAF) overexpression and gene copy number alterations in hepatocellular carcinoma tissues. BMC Cancer. 2021 Mar 20;21(1):295. doi: 10.1186/s12885-021-07994-3. PMID: 33743635; PMCID: PMC7981960.

91.    Han W, Liu M, Han D, Li M, Toure AA, Wang Z, Besschetnova A, Patalano S, Macoska JA, Gao S, He HH, Cai C. RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition. Oncogene. 2022 Feb;41(6):852-864. doi: 10.1038/s41388-021-02135-3. Epub 2022 Jan 3. PMID: 34975152; PMCID: PMC8818029.

92.    Han W, Liu M, Han D, Toure AA, Li M, Besschetnova A, Wang Z, Patalano S, Macoska JA, Lam HM, Corey E, He HH, Gao S, Balk SP, Cai C. Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer. Mol Ther. 2022 Apr 6;30(4):1628-1644. doi: 10.1016/j.ymthe.2022.01.039. Epub 2022 Feb 2. PMID: 35121110; PMCID: PMC9077383.

 

Macoska Laboratory

100 Morrissey Blvd.
BostonMA 02125